Antiviral Activity, Safety, and Pharmacokinetics of Bictegravir as 10-Day Monotherapy in HIV-1–Infected Adults
Journal of Acquired Immune Deficiency Syndromes - United States
doi 10.1097/qai.0000000000001306
Full Text
Open PDFAbstract
Available in full text
Date
May 1, 2017
Authors
Publisher
Ovid Technologies (Wolters Kluwer Health)